article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

The drug featured: Unique delivery mechanism Multiple patents covering formulation and method of use Challenging bioequivalence requirements for potential generics By in-licensing this drug, the company gained a strong market position in a competitive therapeutic area, with generic entry delayed by several years.